81 related articles for article (PubMed ID: 21186377)
1. Cytotoxic activity of nemorosone in human MCF-7 breast cancer cells.
Popolo A; Piccinelli AL; Morello S; Sorrentino R; Osmany CR; Rastrelli L; Pinto A
Can J Physiol Pharmacol; 2011 Jan; 89(1):50-7. PubMed ID: 21186377
[TBL] [Abstract][Full Text] [Related]
2. Effects of nemorosone, isolated from the plant Clusia rosea, on the cell cycle and gene expression in MCF-7 BUS breast cancer cell lines.
Camargo MS; Oliveira MT; Santoni MM; Resende FA; Oliveira-Höhne AP; Espanha LG; Nogueira CH; Cuesta-Rubio O; Vilegas W; Varanda EA
Phytomedicine; 2015 Jan; 22(1):153-7. PubMed ID: 25636884
[TBL] [Abstract][Full Text] [Related]
3. 7-epi-nemorosone from Clusia rosea induces apoptosis, androgen receptor down-regulation and dysregulation of PSA levels in LNCaP prostate carcinoma cells.
Díaz-Carballo D; Gustmann S; Acikelli AH; Bardenheuer W; Buehler H; Jastrow H; Ergun S; Strumberg D
Phytomedicine; 2012 Nov; 19(14):1298-306. PubMed ID: 22981203
[TBL] [Abstract][Full Text] [Related]
4. P2Y2 receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells.
Li HJ; Wang LY; Qu HN; Yu LH; Burnstock G; Ni X; Xu M; Ma B
Mol Cell Endocrinol; 2011 May; 338(1-2):28-37. PubMed ID: 21356271
[TBL] [Abstract][Full Text] [Related]
5. Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer.
Tabuchi Y; Matsuoka J; Gunduz M; Imada T; Ono R; Ito M; Motoki T; Yamatsuji T; Shirakawa Y; Takaoka M; Haisa M; Tanaka N; Kurebayashi J; Jordan VC; Naomoto Y
Int J Oncol; 2009 Feb; 34(2):313-9. PubMed ID: 19148464
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
Lee YR; Park J; Yu HN; Kim JS; Youn HJ; Jung SH
Biochem Biophys Res Commun; 2005 Nov; 336(4):1221-6. PubMed ID: 16169518
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferative activity of brown Cuban propolis extract on human breast cancer cells.
Popolo A; Piccinelli LA; Morello S; Cuesta-Rubio O; Sorrentino R; Rastrelli L; Pinto A
Nat Prod Commun; 2009 Dec; 4(12):1711-6. PubMed ID: 20120113
[TBL] [Abstract][Full Text] [Related]
9. Extraction-dependent effects of American ginseng (Panax quinquefolium) on human breast cancer cell proliferation and estrogen receptor activation.
King ML; Adler SR; Murphy LL
Integr Cancer Ther; 2006 Sep; 5(3):236-43. PubMed ID: 16880429
[TBL] [Abstract][Full Text] [Related]
10. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
Swami S; Krishnan AV; Feldman D
Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
[TBL] [Abstract][Full Text] [Related]
11. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.
Jiang J; Slivova V; Sliva D
Int J Oncol; 2006 Sep; 29(3):695-703. PubMed ID: 16865287
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of estrogenic, antiestrogenic and genotoxic activity of nemorosone, the major compound found in brown Cuban propolis.
Camargo MS; Prieto AM; Resende FA; Boldrin PK; Cardoso CR; Fernández MF; Molina-Molina JM; Olea N; Vilegas W; Cuesta-Rubio O; Varanda EA
BMC Complement Altern Med; 2013 Jul; 13():201. PubMed ID: 23902919
[TBL] [Abstract][Full Text] [Related]
13. Physiologic levels of 2-methoxyestradiol interfere with nongenomic signaling of 17beta-estradiol in human breast cancer cells.
Vijayanathan V; Venkiteswaran S; Nair SK; Verma A; Thomas TJ; Zhu BT; Thomas T
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2038-48. PubMed ID: 16609013
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
Gougelet A; Bouclier C; Marsaud V; Maillard S; Mueller SO; Korach KS; Renoir JM
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):71-81. PubMed ID: 15862952
[TBL] [Abstract][Full Text] [Related]
15. Effects of triptolide from Tripterygium wilfordii on ERalpha and p53 expression in two human breast cancer cell lines.
Liu J; Jiang Z; Xiao J; Zhang Y; Lin S; Duan W; Yao J; Liu C; Huang X; Wang T; Liang Z; Wang R; Zhang S; Zhang L
Phytomedicine; 2009 Nov; 16(11):1006-13. PubMed ID: 19524422
[TBL] [Abstract][Full Text] [Related]
16. Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells.
Liu ZJ; Zhu BT
J Steroid Biochem Mol Biol; 2004 Mar; 88(3):265-75. PubMed ID: 15120420
[TBL] [Abstract][Full Text] [Related]
17. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
18. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
Kim R; Tanabe K; Emi M; Uchida Y; Osaki A; Toge T
Int J Oncol; 2005 Apr; 26(4):1025-31. PubMed ID: 15753998
[TBL] [Abstract][Full Text] [Related]
19. Polyisoprenylated benzophenones in cuban propolis; biological activity of nemorosone.
Cuesta-Rubio O; Frontana-Uribe BA; Ramírez-Apan T; Cárdenas J
Z Naturforsch C J Biosci; 2002; 57(3-4):372-8. PubMed ID: 12064743
[TBL] [Abstract][Full Text] [Related]
20. VP-128, a novel oestradiol-platinum(II) hybrid with selective anti-tumour activity towards hormone-dependent breast cancer cells in vivo.
Van Themsche C; Parent S; Leblanc V; Descôteaux C; Simard AM; Bérubé G; Asselin E
Endocr Relat Cancer; 2009 Dec; 16(4):1185-95. PubMed ID: 19661132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
